Eli Lilly and Company
Patents, Design & Utilities
Last updated:
List of all Eli Lilly and Company patents 385 in total
| Status | Patent |
|---|---|
Application | Utility: SYSTEMS AND METHODS FOR SLEEP DETECTION Filling date: 18 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: PRESERVED FORMULATIONS Filling date: 18 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: POLYMORPHS OF AN FXR AGONIST Filling date: 18 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM Filling date: 18 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST Filling date: 18 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: CD200R agonist antibodies and uses thereof Filling date: 18 Sep 2025 Issue date: 3 May 2022 |
Application | Utility: GIPR-AGONIST COMPOUNDS Filling date: 18 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME Filling date: 18 Sep 2025 Issue date: 28 Apr 2022 |
Grant | Utility: Anti-N3pGlu amyloid beta peptide antibodies and uses thereof Filling date: 18 Sep 2025 Issue date: 26 Apr 2022 |
Application | Utility: MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM Filling date: 18 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: ANTI-ANGPTL 3/8 COMPLEX ANTIBODIES AND METHODS OF USING THE SAME Filling date: 18 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: DEVICES AND PROCESSES FOR DELIVERY OF THERAPEUTIC FLUIDS Filling date: 18 Sep 2025 Issue date: 14 Apr 2022 |
Grant | Utility: Automatic injection system Filling date: 18 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer Filling date: 18 Sep 2025 Issue date: 12 Apr 2022 |
Grant | Utility: Pyrrolidine compounds Filling date: 18 Sep 2025 Issue date: 29 Mar 2022 |
Application | Utility: RAPID-ACTING INSULIN COMPOSITIONS Filling date: 18 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: IL-17A INHIBITORS Filling date: 18 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Determination of a dose in a medication delivery device using two moving arrays with teeth and a sensor Filling date: 18 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Methods of detecting human IL-21 Filling date: 18 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: DOSE REGIMENS FOR USE OF LY3154207 IN THE TREATMENT OF DOPAMINERGIC CNS DISORDERS Filling date: 18 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: METHODS OF TREATING PSORIASIS Filling date: 18 Sep 2025 Issue date: 3 Mar 2022 |
Grant | Utility: GIPR-agonist compounds Filling date: 18 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Fusion proteins and methods of use Filling date: 18 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: GIP/GLP1 CO-AGONIST COMPOUNDS Filling date: 18 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: Anti-Alpha-Synuclein Antibodies and Uses Thereof Filling date: 18 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: Novel Treprostinil Salt Filling date: 18 Sep 2025 Issue date: 17 Feb 2022 |
Application | Utility: METHODS OF TREATING CROHN'S DISEASE Filling date: 18 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Neuregulin-4 compounds and methods of use Filling date: 18 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Anti-ANGPTL 3/8 complex antibodies and methods of using the same Filling date: 18 Sep 2025 Issue date: 8 Feb 2022 |
Application | Utility: METHODS AND APPARATUS FOR ASPECTS OF A DOSE DETECTION SYSTEM MODULE FOR A MEDICATION DELIVERY DEVICE Filling date: 18 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: DRUG-DELIVERY SYSTEMS INCLUDING DRUG-DELIVERY DEVICE ASSEMBLIES FOR ATTACHING TO INFUSION HUBS Filling date: 18 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME Filling date: 18 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: 7 (METHYLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE DERIVATIVES Filling date: 18 Sep 2025 Issue date: 27 Jan 2022 |
Grant | Utility: Medication delivery device with mechanical locking system Filling date: 18 Sep 2025 Issue date: 25 Jan 2022 |
Application | Utility: DISUBSTITUTED PYRAZOLE COMPOUNDS Filling date: 18 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: COMBINATION THERAPY WITH NOTCH AND PD-1 OR PD-L1 INHIBITORS Filling date: 18 Sep 2025 Issue date: 13 Jan 2022 |
Grant | Design: Display screen with a graphical user interface Filling date: 18 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Design: Display screen with animated graphical user interface Filling date: 18 Sep 2025 Issue date: 11 Jan 2022 |
Grant | Design: Display screen with animated graphical user interface Filling date: 18 Sep 2025 Issue date: 11 Jan 2022 |
Application | Utility: AN AURORA A KINASE INHIBITOR FOR USE IN THE TREATMENT OF NEUROBLASTOMA Filling date: 18 Sep 2025 Issue date: 6 Jan 2022 |
Grant | Utility: 2,3-dihydrofuro[2,3-b]pyridine compounds Filling date: 18 Sep 2025 Issue date: 4 Jan 2022 |
Grant | Utility: Cyclohexyl benzamide compounds Filling date: 18 Sep 2025 Issue date: 4 Jan 2022 |
Application | Utility: SELECTIVE ESTROGEN RECEPTOR DEGRADERS Filling date: 18 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: Antibodies that bind TGF-Alpha and Epiregulin for use in the treatment of pain Filling date: 18 Sep 2025 Issue date: 30 Dec 2021 |
Grant | Utility: KCNQ potentiators Filling date: 18 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Rapid-acting insulin compositions Filling date: 18 Sep 2025 Issue date: 28 Dec 2021 |
Application | Utility: ENDOCRINE THERAPY AND ABEMACICLIB COMBINATION FOR THE ADJUVANT TREATMENT OF NODE-POSITIVE, EARLY STAGE, HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE BREAST CANCER Filling date: 18 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: DEVICES FOR RECONSTITUTING AND DELIVERING LYOPHILIZED DRUGS Filling date: 18 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Checkpoint inhibitor bispecific antibodies Filling date: 18 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Treatment of primary biliary cholangitis and primary sclerosing cholangitis with baricitinib Filling date: 18 Sep 2025 Issue date: 14 Dec 2021 |
Showing 50 to 100 of 385 patents.